Auris

Auris Health is a medical technology company specializing in surgical robotics and minimally invasive procedures. The company is best known for its Monarch Platform, an FDA-cleared robotic system designed for diagnostic and therapeutic bronchoscopic procedures, particularly in the early detection and treatment of lung cancer. Founded by surgical robotics pioneer Dr. Frederic Moll, Auris Health integrates robotics, micro-instrumentation, and data science to enhance physician capabilities and improve patient outcomes. In 2019, the company was acquired by Johnson & Johnson for $3.4 billion, becoming a key part of J&J's digital surgery and lung cancer initiatives.